The new "efficiency gains" associated with doing away with images may sound like clever marketing sloganeering, but I do have an uneasy feeling about Illumina trying to close their system. As a group of bioinformatics researchers I would think open source is the way we want things and closing off systems will only serve to stifle research. I happily admit to have made use of images to salvage runs, but even good runs can be noticeably improved with open source methods. So I certainly am troubled, what about others?
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
Originally posted by zero View PostThe new "efficiency gains" associated with doing away with images may sound like clever marketing sloganeering, but I do have an uneasy feeling about Illumina trying to close their system. As a group of bioinformatics researchers I would think open source is the way we want things and closing off systems will only serve to stifle research. I happily admit to have made use of images to salvage runs, but even good runs can be noticeably improved with open source methods. So I certainly am troubled, what about others?
We've had several runs which, had we not had access to the original images, would have been complete failures, but which we were able to successfully recover. In some cases you could just rerun the sample, but sometimes it's not that simple (scarce samples, time pressures, unusual runs etc). I'm wary about moving to the latest SCS since, with our current hardware, we won't be able to save images and this increases the chances of us losing data.
I should say, we don't keep images for long. Once we know that we have a reasonable amount of data from a lane and that it looks sensible we delete the images. The impact on our infrastructure is therefore very small, but the extra redundancy it provides is invaluable.
Comment
Latest Articles
Collapse
-
by seqadmin
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...-
Channel: Articles
04-04-2024, 04:25 PM -
-
by seqadmin
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...-
Channel: Articles
03-22-2024, 06:39 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 04-11-2024, 12:08 PM
|
0 responses
18 views
0 likes
|
Last Post
by seqadmin
04-11-2024, 12:08 PM
|
||
Started by seqadmin, 04-10-2024, 10:19 PM
|
0 responses
22 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 10:19 PM
|
||
Started by seqadmin, 04-10-2024, 09:21 AM
|
0 responses
17 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 09:21 AM
|
||
Started by seqadmin, 04-04-2024, 09:00 AM
|
0 responses
49 views
0 likes
|
Last Post
by seqadmin
04-04-2024, 09:00 AM
|
Comment